De-Risking Investments in Medical Technology Innovation
Strengthening decision-making and valuation accuracy in early-stage medical startups.
The high failure rates of medical startups have discouraged many potential investors, depriving the sector of precious financial resources. In the last two decades, managing early-stage medical technology ventures hasn’t gotten easier: it still means facing high levels of complexity due to many factors, such as the challenging prediction of the behavior of numerous stakeholders with conflicting priorities, the stretched breadth of competencies required of medical entrepreneurs, and the fast accelerating rate of growth of global medical knowledge. The reader of this book will find practical tools that help navigate the map of critical decision problems—those inhabiting the critical path that begins with an innovative idea and ends with the highly sought-after monetization. Addressing these problems with high-quality decisions can make the difference between successful value creation and expensive failure.
_PNG.png)
The Springer Series in Healthcare Management and Innovation presents a curated collection of research monographs, contributed volumes, and professional titles that illuminate emerging theories, empirical studies, practical applications, strategic frameworks, and real-world case studies in healthcare. Each volume addresses a broad spectrum of topics in healthcare management and innovation, including—but not limited to—leadership, financial management, ethics and corporate social responsibility (CSR), human resource management, managed care, workforce and patient diversity, research and development (R&D) of medical technologies, organizational strategy and planning, and healthcare information systems.